SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-044320
Filing Date
2018-02-14
Accepted
2018-02-14 08:31:59
Documents
5
Period of Report
2018-02-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d499642d8k.htm 8-K 43783
2 EX-10.1 d499642dex101.htm EX-10.1 99097
3 EX-99.1 d499642dex991.htm EX-99.1 78521
4 GRAPHIC g499642g0214053211709.jpg GRAPHIC 3085
5 GRAPHIC g499642g0214053211799.jpg GRAPHIC 2006
  Complete submission text file 0001193125-18-044320.txt   230233
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 18607337
SIC: 2834 Pharmaceutical Preparations